Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-21-000308

Director sold 4,000 shares at $481.52 ($1,926,065)

  • Director acquired 4,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Nusse Roeland · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-23 Exercise or conversion : show line 1 in the form +4,000 $70.35 $281,400 10,765 D
2021-08-23 Sale : show line 2 in the form −4,000 $481.52 $1,926,065 6,765 D
Open-market sales · 4,000 sh · avg $481.52 · $1,926,065

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-08-23 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −4,000 0 D
Loading xslF345X03/edgar.xml…